- Sector
- Healthcare
- Industry
- Biotechnology
- IPO Date
- Feb 14, 2012
Highlights
- Market Cap
- $885.15K
- Enterprise Value
- -$3.24M
- EPS (TTM)
- -$0.84
- Total Revenue (TTM)
- $142.00K
- Gross Profit (TTM)
- $142.00K
- EBITDA (TTM)
- -$979.00K
- Year Range
- $0.31 - $5.30
- ROA (TTM)
- -16.61%
- ROE (TTM)
- 111.65%
- Avg. Volume (1M)
- 11M
- Avg. Volume Value (1M)
- $7.04M
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
VIVS Performance Chart
VivoSim Labs, Inc (VIVS) is down 81.0% since the beginning of the year. At $0 per share, VIVS is trading 93.5% below its 52-week high of $5. Investors who bought $1,000 worth of VIVS shares 5 years ago would now be looking at an investment worth $4.
Loading charts...
Compare this symbol against anything
Returns By Period
VivoSim Labs, Inc (VIVS) has returned -80.96% so far this year and -81.37% over the past 12 months. Over the last ten years, VIVS has returned -55.04% per year, falling short of the S&P 500 Index benchmark, which averaged 13.26% annually.
VivoSim Labs, Inc
- 1D
- -10.73%
- 1M
- -64.84%
- 6M
- -88.20%
- YTD
- -80.96%
- 1Y
- -81.37%
- 3Y*
- -73.87%
- 5Y*
- -67.29%
- 10Y*
- -55.04%
- ALL TIME*
- -38.58%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
VIVS Monthly Returns History
Based on dividend-adjusted daily data since Feb 14, 2012, VIVS's average daily return is +0.03%, while the average monthly return is -1.11%.
Historically, 41% of months were positive and 59% were negative. The best month was May 2012 with a return of +95.2%, while the worst month was Mar 2025 at -71.3%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 7 months.
On a daily basis, VIVS closed higher 44% of trading days. The best single day was Feb 25, 2025 with a return of +244.2%, while the worst single day was Jun 27, 2012 at -58.6%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 61.33% | -25.68% | -34.10% | 0.00% | -8.39% | -18.32% | -67.79% | -80.96% | |||||
| 2025 | -21.40% | 79.81% | -71.28% | -12.95% | -7.69% | -18.33% | 27.21% | 30.48% | 19.67% | -7.53% | -17.04% | -19.20% | -67.20% |
| 2024 | -8.11% | -0.00% | 0.98% | 3.88% | -8.11% | -22.49% | -26.52% | 3.57% | -12.24% | -11.14% | 6.12% | -4.19% | -58.57% |
| 2023 | 15.60% | 45.40% | -7.59% | -10.96% | -12.82% | -0.59% | -1.18% | -28.14% | 4.17% | -15.20% | 10.38% | -5.13% | -21.28% |
| 2022 | -14.05% | 14.10% | 5.62% | -23.67% | -16.03% | -26.56% | 66.10% | -19.73% | -13.14% | -20.00% | -7.93% | -6.62% | -61.16% |
| 2021 | 3.98% | -0.31% | -24.39% | -11.41% | 10.07% | 0.00% | -18.40% | -0.13% | -11.23% | -8.68% | -22.87% | -24.22% | -70.49% |
Benchmark Metrics
VivoSim Labs, Inc has an annualized alpha of -5.55%, beta of 1.01, and R2 of 0.02 versus S&P 500 Index. Calculated based on daily prices since February 14, 2012.
- This stock participated in 236.42% of S&P 500 Index downside but only 14.60% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.02 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -5.55%
- Beta
- 1.01
- R²
- 0.02
- Upside Capture
- 14.60%
- Downside Capture
- 236.42%
Return for Risk
Risk / Return Rank
VIVS ranks 10 for risk / return — above 10% of stocks peers on PortfoliosLab. Its historical combined result is below most peers; review the five component ranks for context.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for VivoSim Labs, Inc (VIVS) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| VIVS | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.06 | ||
| Sortino ratioReturn per unit of downside risk | -3.24 | ||
| Omega ratioGain probability vs. loss probability | 0.85 | 1.25 | -0.40 |
| Calmar ratioReturn relative to maximum drawdown | -0.88 | 2.00 | -2.88 |
| Martin ratioReturn relative to average drawdown | -1.38 | 8.49 | -9.87 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the VivoSim Labs, Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the VivoSim Labs, Inc was 99.99%, occurring on Jul 31, 2026. The portfolio has not yet recovered.
The current VivoSim Labs, Inc drawdown is 99.99%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-99.99%Jul 2026 | 12y 8mo | — | 12y 8moNov 2013 - now | — |
-83.83%Jul 2012 | 1mo 1d | 1y 3mo | 1y 4moJun 2012 - Nov 2013 | — |
-25.45%Apr 2012 | 10d | 13d | 23dApr 2012 - May 2012 | — |
-24.85%Feb 2012 | 8d | 3d | 11dFeb 2012 - Feb 2012 | — |
-14.95%Jun 2012 | 1d | 5d | 6dJun 2012 - Jun 2012 | — |
Drawdown Indicators
| VIVS | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.99% | -56.78% | -43.21% |
Max Drawdown (1Y)Largest decline over 1 year | -92.79% | -9.10% | -83.69% |
Max Drawdown (3Y)Largest decline over 3 years | -98.44% | -18.90% | -79.54% |
Max Drawdown (5Y)Largest decline over 5 years | -99.65% | -25.43% | -74.22% |
Max Drawdown (10Y)Largest decline over 10 years | -99.97% | -33.92% | -66.05% |
Current DrawdownCurrent decline from peak | -99.99% | -1.58% | -98.41% |
Average DrawdownAverage peak-to-trough decline | -81.99% | -10.70% | -71.29% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 58.96% | 2.14% | +56.82% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of VivoSim Labs, Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how VivoSim Labs, Inc is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for VIVS relative to other companies in the Biotechnology industry. Currently, VIVS has a P/S ratio of 3.6. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with VIVS
Add VivoSim Labs, Inc to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with VIVS